{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/CNTB/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-18T16:01:37.445Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":4604,"canonical_name":"Connect Biopharma Holdings Ltd","cik":"0001835268","uei":null,"lei":null,"duns":null,"ticker":"CNTB"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":17},"count":17,"timeline":[{"ts":"2026-10-01","kind":"sec.filing","form_type":"4","title":"4 — Connect Biopharma Holdings Ltd — 2026-10-01","url_slug":"/sec/cik-0001835268/4/0002115875-26-000007","accession_number":"0002115875-26-000007","importance":30},{"ts":"2026-09-30","kind":"sec.filing","form_type":"8-K","title":"8-K — Connect Biopharma Holdings Ltd — 2026-09-30","url_slug":"/sec/cik-0001835268/8-k/0001835268-26-000038","accession_number":"0001835268-26-000038","importance":35},{"ts":"2026-09-15","kind":"sec.filing","form_type":"8-K","title":"8-K — Connect Biopharma Holdings Ltd — 2026-09-15","url_slug":"/sec/cik-0001835268/8-k/0001835268-26-000034","accession_number":"0001835268-26-000034","importance":35},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Connect Biopharma Holdings Ltd — 2026-08-14","url_slug":"/sec/cik-0001835268/schedule-13g-a/0001913491-26-000005","accession_number":"0001913491-26-000005","importance":30},{"ts":"2026-08-12","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Connect Biopharma Holdings Ltd — 2026-08-12","url_slug":"/sec/cik-0001835268/10-q/0001835268-26-000028","accession_number":"0001835268-26-000028","importance":45},{"ts":"2026-08-12","kind":"sec.filing","form_type":"8-K","title":"8-K — Connect Biopharma Holdings Ltd — 2026-08-12","url_slug":"/sec/cik-0001835268/8-k/0001835268-26-000027","accession_number":"0001835268-26-000027","importance":35},{"ts":"2026-07-01","kind":"sec.filing","form_type":"4","title":"4 — Connect Biopharma Holdings Ltd — 2026-07-01","url_slug":"/sec/cik-0001835268/4/0001835268-26-000022","accession_number":"0001835268-26-000022","importance":30},{"ts":"2026-06-30","kind":"sec.insider.a","reporter":"LIU JEAN I","title":null,"shares":6718,"price_per_share":0,"usd_value":0,"security_title":"Ordinary Shares","importance":15},{"ts":"2026-06-30","kind":"sec.insider.a","reporter":"Xanthopoulos Kleanthis Gabriel","title":null,"shares":3738,"price_per_share":0,"usd_value":0,"security_title":"Ordinary Shares","importance":15},{"ts":"2026-06-01","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — Connect Biopharma Holdings Ltd — 2026-06-01","url_slug":"/sec/cik-0001835268/effect/9999999995-26-001825","accession_number":"9999999995-26-001825","importance":30},{"ts":"2026-05-29","kind":"sec.insider.p","reporter":"Huang James","title":null,"shares":150000,"price_per_share":2.4774,"usd_value":371610,"security_title":"Ordinary Shares","importance":50.37161},{"ts":"2026-05-28","kind":"sec.filing","form_type":"CORRESP","title":"CORRESP — Connect Biopharma Holdings Ltd — 2026-05-28","url_slug":"/sec/cik-0001835268/corresp/0001193125-26-245157","accession_number":"0001193125-26-245157","importance":30},{"ts":"2026-05-22","kind":"sec.filing","form_type":"UPLOAD","title":"UPLOAD — Connect Biopharma Holdings Ltd — 2026-05-22","url_slug":"/sec/cik-0001835268/upload/0000000000-26-005249","accession_number":"0000000000-26-005249","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"F-3","title":"F-3 — Connect Biopharma Holdings Ltd — 2026-05-15","url_slug":"/sec/cik-0001835268/f-3/0001193125-26-225436","accession_number":"0001193125-26-225436","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Connect Biopharma Holdings Ltd — 2026-05-15","url_slug":"/sec/cik-0001835268/schedule-13g-a/0001913491-26-000003","accession_number":"0001913491-26-000003","importance":30},{"ts":"2026-05-12","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Connect Biopharma Holdings Ltd — 2026-05-12","url_slug":"/sec/cik-0001835268/10-q/0001835268-26-000020","accession_number":"0001835268-26-000020","importance":45},{"ts":"2026-05-12","kind":"sec.filing","form_type":"8-K","title":"8-K — Connect Biopharma Holdings Ltd — 2026-05-12","url_slug":"/sec/cik-0001835268/8-k/0001835268-26-000019","accession_number":"0001835268-26-000019","importance":35}]}